Predicción y previsión de precio de NervGen Pharma Corp (NGEN)

$1.320

-0.029 (-2.22%)Al cierre

Predicciones de precio

1-Day Price Prediction

+0.41%

1-Week Prediction

-2.83%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

Ábrelo en la app para desbloquear previsiones a más largo plazo.

Loading chart…

Predicción y previsión de NGEN por análisis de gráficos similares

Alphio's NGEN stock price prediction model matches the current NervGen Pharma Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.33 (+0.41%). The 1-week path is $1.28 (-2.83%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

¿Debería comprar acciones de NervGen Pharma Corp?

Nervgen Pharma Corp. is not a good buy right now. The current price is $1.35, which is significantly below the 52-week high of $6.30, indicating a steep decline of 78.40% year-to-date. Additionally, the RSI is at a very low 21.92, suggesting oversold conditions, but this may not be a strong enough signal to counteract the negative financial performance, including a net income loss of CAD 29,217,233 in Q2 2026. The main risk is the ongoing equity dilution from the recent public offering, which could further depress the stock price.